智飞生物上榜2025重庆民营企业科技创新指数100强

Core Insights - The Chongqing Private Economy Innovation and Development Conference successfully held on December 26, where the "2025 Chongqing Private Enterprises Technology Innovation Index Top 100 List" was officially released, with Zhifei Biological ranking 3rd in the index and 4th in the R&D investment list [1][3]. Group 1: Company Achievements - Zhifei Biological has consistently adhered to an innovation strategy focused on independent research and development, increasing R&D investment, and enhancing pipeline layout, with a cumulative R&D investment exceeding 6 billion yuan over the past three years [3]. - The company has made significant progress in multiple self-developed projects this year, entering a period of intensive innovation achievements [3]. Group 2: Product Development - In the prevention field, Zhifei Biological has launched several vaccines, including a quadrivalent influenza virus split vaccine and a rabies vaccine, with various other products in different stages of approval and clinical trials [5]. - The company has a total of 34 self-developed projects in the prevention field, with 24 projects currently in the application, clinical trial, or approval stages [5]. - In the treatment field, Zhifei Biological has 8 self-developed projects, with 7 in clinical trials or registration application stages, including liraglutide injection and insulin products [5]. Group 3: Innovation and Future Plans - Zhifei Biological has successfully incubated over ten technology enterprises through its Zhihui Investment platform, with more than fifty projects in development, leading the industry in the progress of several first-class new drugs [6]. - The company aims to launch one to two first-class innovative drugs annually from its incubated enterprises over the next decade, significantly advancing the high-end development of Chongqing's biopharmaceutical industry [6]. - The recognition in the Chongqing Private Enterprises Technology Innovation Index is an authoritative acknowledgment of Zhifei Biological's R&D investment, technical accumulation, and innovation achievements, with plans to strengthen its innovation position and contribute to high-quality development in the biopharmaceutical industry [6].